Showing results (471-480 of 501) with videos related to

Sort By:
Pageof 51
Behavioral Sleep Medicine|April 16, 2026
Experiential Avoidance is Associated with Insomnia Symptoms and Related Consequences Among Veterans with Posttraumatic Stress DisorderGwendolyn C Carlson, Alaina I Gold, Alexander J Erickson, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|December 24, 2011
Localized 5f electrons in superconducting PuCoIn₅: consequences for superconductivity in PuCoGa₅E D Bauer, M M Altarawneh, P H Tobash, et al.
Plos Neglected Tropical Diseases|January 21, 2025
Incompatible Aedes aegypti male releases as an intervention to reduce mosquito population-A field trial in Puerto RicoLiliana Sánchez-González, Jacob E Crawford, Laura E Adams, et al.
Science (New York, N.Y.)|November 29, 2014
Mosquito genomics. Extensive introgression in a malaria vector species complex revealed by phylogenomicsMichael C Fontaine, James B Pease, Aaron Steele, et al.
National Science Review|December 15, 2025
Multipolarized radar reveals shallow subsurface structure and middle-late Amazonian aqueous activity in Utopia Planitia, MarsYike Liu, Tianfan Yan, Xiaoguang Qin, et al.
Nature Communications|March 13, 2021
Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypesJames A Diao, Jason K Wang, Wan Fung Chui, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppresses atrial fibrillationNoor Momin, Steffen Pabel, Arnab Rudra, et al.
Physiological Reports|October 2, 2025
Multiomics investigation of the female hypertensive human heartZachary J Milstone, Jesse D Moreira-Bouchard, Karan K Smith, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 1, 2021
The Autophagy Inducer Spermidine Protects Against Metabolic Dysfunction During OvernutritionChen-Yu Liao, Oona M P Kummert, Amanda M Bair, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2017
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of DepressionJ M Witkin, S N Mitchell, K A Wafford, et al.
Pageof 51